WO2005059546A3 - Diagnostics et therapeutique destines au traitement de maladies associees au recepteur couple aux proteines g 35 (gpr35) - Google Patents
Diagnostics et therapeutique destines au traitement de maladies associees au recepteur couple aux proteines g 35 (gpr35) Download PDFInfo
- Publication number
- WO2005059546A3 WO2005059546A3 PCT/EP2004/013679 EP2004013679W WO2005059546A3 WO 2005059546 A3 WO2005059546 A3 WO 2005059546A3 EP 2004013679 W EP2004013679 W EP 2004013679W WO 2005059546 A3 WO2005059546 A3 WO 2005059546A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- disorders
- diseases
- gpr35
- therapeutics
- diagnostics
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
- G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Cell Biology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Pathology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Food Science & Technology (AREA)
- Biotechnology (AREA)
- General Physics & Mathematics (AREA)
- Microbiology (AREA)
- Organic Chemistry (AREA)
- Toxicology (AREA)
- Neurosurgery (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Neurology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP03028614.0 | 2003-12-12 | ||
EP03028614 | 2003-12-12 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2005059546A2 WO2005059546A2 (fr) | 2005-06-30 |
WO2005059546A3 true WO2005059546A3 (fr) | 2006-02-23 |
Family
ID=34684539
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP2004/013679 WO2005059546A2 (fr) | 2003-12-12 | 2004-12-02 | Diagnostics et therapeutique destines au traitement de maladies associees au recepteur couple aux proteines g 35 (gpr35) |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2005059546A2 (fr) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2006025551A1 (fr) * | 2004-08-30 | 2006-03-09 | Takeda Pharmaceutical Company Limited | Méthode de criblage |
PL228037B1 (pl) * | 2009-03-23 | 2018-02-28 | Marciniak Agnieszka Maria | Zastosowanie kwasu kynureninowego w zapobieganiu lub leczeniu chorób trzustki |
US20120022116A1 (en) * | 2010-07-20 | 2012-01-26 | Huayun Deng | Compositions and methods for the treatment of pathological condition(s) related to gpr35 and/or gpr35-herg complex |
WO2013022740A2 (fr) * | 2011-08-05 | 2013-02-14 | Corning Incorporated | Ligands de gpr35 et leurs utilisations |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2000008155A2 (fr) * | 1998-08-07 | 2000-02-17 | Incyte Pharmaceuticals, Inc. | Proteines associees a un recepteur humain |
WO2000023603A2 (fr) * | 1998-10-21 | 2000-04-27 | Arch Development Corporation | Procede de traitement des diabetes de type 2 |
WO2002068600A2 (fr) * | 2001-02-26 | 2002-09-06 | Arena Pharmaceuticals, Inc. | Versions endogene et non endogenes de recepteurs humains couples aux proteines g |
WO2003071272A1 (fr) * | 2002-02-22 | 2003-08-28 | Takeda Chemical Industries, Ltd. | Methode de determination d'un ligand |
WO2003087366A1 (fr) * | 2002-04-16 | 2003-10-23 | Kyowa Hakko Kogyo Co., Ltd. | Lignees de cellules endocriniennes et procede d'utilisation desdites lignees |
-
2004
- 2004-12-02 WO PCT/EP2004/013679 patent/WO2005059546A2/fr active Application Filing
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2000008155A2 (fr) * | 1998-08-07 | 2000-02-17 | Incyte Pharmaceuticals, Inc. | Proteines associees a un recepteur humain |
WO2000023603A2 (fr) * | 1998-10-21 | 2000-04-27 | Arch Development Corporation | Procede de traitement des diabetes de type 2 |
WO2002068600A2 (fr) * | 2001-02-26 | 2002-09-06 | Arena Pharmaceuticals, Inc. | Versions endogene et non endogenes de recepteurs humains couples aux proteines g |
WO2003071272A1 (fr) * | 2002-02-22 | 2003-08-28 | Takeda Chemical Industries, Ltd. | Methode de determination d'un ligand |
EP1477806A1 (fr) * | 2002-02-22 | 2004-11-17 | Takeda Chemical Industries, Ltd. | Methode de determination d'un ligand |
WO2003087366A1 (fr) * | 2002-04-16 | 2003-10-23 | Kyowa Hakko Kogyo Co., Ltd. | Lignees de cellules endocriniennes et procede d'utilisation desdites lignees |
EP1498483A1 (fr) * | 2002-04-16 | 2005-01-19 | Kyowa Hakko Kogyo Co., Ltd. | Lignees de cellules endocriniennes et procede d'utilisation desdites lignees |
Also Published As
Publication number | Publication date |
---|---|
WO2005059546A2 (fr) | 2005-06-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2005106492A3 (fr) | Diagnostic et traitement therapeutique des maladies associees au recepteur 3 de la chimiokine c-c (ccr3) | |
WO2005093092A3 (fr) | Diagnostic et traitement de maladies associees au recepteur 44 couple aux proteines g (gpr44) | |
WO2005095973A3 (fr) | Methodes diagnostiques et therapeutiques pour des maladies associees au recepteur 54 couple a la proteine g (gpr54) | |
WO2005103702A3 (fr) | Methodes diagnostiques et therapeutiques pour lutter contre les maladies associees au recepteur 2 de la chimiokine cxc (cxcr2) | |
WO2005040828A3 (fr) | Agents de diagnostic et de traitement des maladies associees au recepteur 49 couple aux proteines g (gpr49) | |
WO2005050225A3 (fr) | Outils de diagnostic et de traitement de maladies associees au recepteur 84 couple aux proteines g (gpr84) | |
WO2005059546A3 (fr) | Diagnostics et therapeutique destines au traitement de maladies associees au recepteur couple aux proteines g 35 (gpr35) | |
WO2005093091A3 (fr) | Agents diagnostiques et therapeutiques pour maladies associees au recepteur 26 couple a la proteine g (gpr26) | |
WO2004082568A3 (fr) | Diagnostics et traitements contre des maladies associees au recepteur 5a du composant du complement (c5ar) | |
WO2005040211A3 (fr) | Composes destines au diagnostic et au traitement de maladies associees au recepteur 1 couple aux proteines g (gpr1) | |
WO2005040825A3 (fr) | Diagnostics et therapeutiques pour maladies liees au recepteur 20 couple a la proteine g (gpr20) | |
WO2004104574A3 (fr) | Agents diagnostiques et therapeutiques destines a des maladies associees au recepteur de chimiokine c-c de type 7 (ccr7) | |
WO2004082571A3 (fr) | Diagnostics et therapies pour maladies associees au recepteur 86 couple a la proteine g (gpr86) | |
WO2005108998A3 (fr) | Methodes de diagnostic et de traitement de maladies associees au recepteur couple aux proteines g adrenergique beta-3 (adrb3) | |
WO2005040824A3 (fr) | Diagnostics et therapeutiques pour maladies liees au recepteur 24 couple a la proteine g (gpr24) | |
WO2005103711A3 (fr) | Agents diagnostiques et therapeutiques pour des maladies associees au recepteur 1 des chimiokines cxc (cxcr1) | |
WO2004104577A3 (fr) | Approches diagnostiques et therapeutiques des maladies associees au recepteur 5-hydroxytryptamine 4 (5-ht4)(serotonine) | |
WO2004099248A3 (fr) | Produits de diagnostic et de traitement de maladies associees au recepteur agtr2 couple aux proteines g (agtr2) | |
WO2005040822A3 (fr) | Diagnostics et therapeutiques pour des maladies associees au recepteur 25 couple a la proteine g (gpr25) | |
WO2004082572A3 (fr) | Diagnostics et therapies pour les maladies associees au recepteur 87 couple a la proteine g (gpr87) | |
WO2005040829A3 (fr) | Agents de diagnostic et de traitement des maladies associees au recepteur 17 couple aux proteines g (gpr17) | |
WO2005040790A3 (fr) | Diagnostics et therapeutiques pour maladies liees au recepteur 75 couple a la proteine g (gpr75) | |
WO2004106934A3 (fr) | Diagnostics et agents therapeutiques destines a des maladies liees au recepteur 7 de 5-hydroxytryptamine (serotonine) (5-ht7) | |
WO2004106935A3 (fr) | Agents diagnostiques et therapeutiques destines a des maladies associees au recepteur 103 couples aux proteines g (gpr103) | |
WO2005003762A3 (fr) | Procedes pour diagnostiquer et traiter des maladies associees au recepteur 2 couple a la proteine g specifique aux neurones sensoriels (snsr2) |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
122 | Ep: pct application non-entry in european phase |